Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001209525 | SCV001380963 | uncertain significance | Fanconi anemia complementation group E | 2019-09-18 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with FANCE-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This sequence change replaces glutamine with proline at codon 75 of the FANCE protein (p.Gln75Pro). The glutamine residue is weakly conserved and there is a moderate physicochemical difference between glutamine and proline. |
Sema4, |
RCV002256699 | SCV002527952 | uncertain significance | Fanconi anemia | 2022-01-06 | criteria provided, single submitter | curation |